Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Viemed Healthcare Inc VMD

Viemed Healthcare, Inc. through its subsidiaries, is a provider of home medical equipment (HME) and post-acute respiratory healthcare services in the United States. The Company’s service offerings are focused on effective in-home treatment with clinical practitioners providing therapy and counselling to patients in their homes using cutting edge technologies. The Company’s products and services... see more

NDAQ:VMD - Post Discussion

Viemed Healthcare Inc > VMD: Dirt-cheap at <2x revenue and <7x adj. EBITDA in 2021
View:
Post by stockfy on Jun 04, 2021 4:01am

VMD: Dirt-cheap at <2x revenue and <7x adj. EBITDA in 2021

VMD has overreacted over the last days and has become technically oversold. Technicals aside, VMD's revenue and adj. EBITDA in 2021 will be at least $150 million and $45 million, respectively.

VMD also has a pristine balance sheet with net cash of about $24 million, I mean the cash exceed debt by $24 million.

As a result, VMD's Enterprise Value currently is less than 2 times its 2021 revenue and less than 7 times its 2021 adj. EBITDA, so VMD is dirt-cheap on relative and absolute valuation analysis! 

The aforementioned estimates do not include extra revenue coming from the many growth initiatives mentioned in the latest two Conference Calls, especially the last CC.

Both the CEO and the COO were very clear in the latest Conference Call. VMD has been working on many fronts and will increase significantly its revenue this year thanks to organic and inorganic (acquisitions) initiatives.
 
 
Comment by stockfy on Jun 04, 2021 8:53am
All these facts below hurt besttobe alias and his agenda against VMD.   Besttobe alias, the resident disgruntled employee, created his alias in 2019 and he has posted numerous negative messages on VMD's board over the last couple of years. In his numerous messages, besttobe alias has twisted the truth multiple times and/or he has made highly inaccurate remarks or he has posted outright ...more  
Comment by lscfa on Jun 04, 2021 9:04am
Wrong.     Revenue 2020 Actual 2022 analysts est. Increase Core biz + Covid 131.3 133.6 1.8% Core biz 96.9 133.6 37.9%    ...more